🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Perspective Therapeutics, Inc.

CATX Healthcare
$3.2 +$0.1 (3.23%)
Market Cap: $365.29 M
Gurus Holding
4
Popularity Rank
#2495
% of Shares Held
0.25%
Net Activity (Q2 2026)
+$152,001.61

Guru Ownership Trend

Guru Analysis for Perspective Therapeutics, Inc. (CATX)

Perspective Therapeutics, Inc. (CATX), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $923,452.8.

Top institutional holders include Jefferies Group and Renaissance Technologies (RenTech).

Institutional sentiment is currently Bullish. This is evidenced by a $152,001.61 net inflow during the quarter.

Recent activity highlights Jefferies Group who opened a new position. Conversely, Paul Tudor Jones reduced exposure by 46.7%.

Key Holders

Recent Activity Breakdown (Q2 2026)

+$206,015.61
Total Buy Value
New Buys 1
Additions 1
-$54,014
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
1
Net Buyers
2

FAQs for Perspective Therapeutics, Inc. (CATX)

Major holders include Jefferies Group ($764,536), Renaissance Technologies (RenTech) ($201,644), Cliff Asness ($95,473). According to the latest reported data, 4 tracked investment managers collectively hold approximately 288,579 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $152,001.61, with 2 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited CATX. The total reported sell value was $54,014.

Yes, 1 managers opened new positions in CATX, and 1 increased their existing holdings. The total reported buy value was $206,015.61.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.01% New Buy 183,342 $764,536 Q1 2026
0.00% New Buy 59,133 $201,644 Q2 2026
0.00% Add 4.8% 27,998 $95,473 Q2 2026
0.00% Reduce -46.7% 18,106 $61,741 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form